16-Jan-2026 12:10 AM CST - Yahoo Finance Is Labcorp (LH) Quietly Reframing Its Oncology Innovation Story With Dividends And MRD Expansion? Earlier this week, Labcorp Holdings Inc. declared a quarterly cash dividend of US$0.72 per share, payable on March 12, 2026 to shareholders of record as of February 27, 2026. In parallel, Labcorp expanded its Plasma Detect molecular residual disease portfolio with highly sensitive ctDNA tests for breast,
15-Jan-2026 3:14 PM CST - Yahoo Finance UK Labcorp to Announce Fourth Quarter Financial Results on February 17, 2026 Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the fourth quarter of 2025 before the market opens on Tuesday,
13-Jan-2026 6:45 AM CST - Yahoo Finance Labcorp Expands MRD Testing for Breast, Lung and Colon Cancer Recurrence Risk Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the continued expansion of its molecular residual disease (MRD)i portfolio designed to help clinicians detect cancer recurrence earlier than traditional imaging.
31-Dec-2025 9:01 AM CST - Investing Snacks Labcorp Investor Conference at J.P. Morgan Labcorp will host a fireside chat at the J.P. Morgan Healthcare Conference. Get details on the Labcorp investor conference, webcast, and replay for their business outlook.
9-Dec-2025 3:50 AM CST - Yahoo Finance Labcorp (LH) Valuation Check After Steady Share Price Climb and Solid Total Return Labcorp Holdings (LH) has quietly outperformed many healthcare peers this year, and the stock's recent move has investors asking whether steady earnings growth and diagnostics demand can keep driving gains from here.
25-Nov-2025 6:04 PM CST - Yahoo Finance Labcorp Holdings Stock: Analyst Estimates & Ratings While Labcorp Holdings has underperformed the S&P 500 Index slightly over the past year, its YTD strength stands out. Analysts remain firmly bullish on the stock's growth potential.
Latest LH Trades by Congress Members
17-NOV-2025 - April McClain Delaney, MD (District 6) purchased between $1,001 and $15,000.
16-Jan-2026 12:10 AM CST - Yahoo Finance Is Labcorp (LH) Quietly Reframing Its Oncology Innovation Story With Dividends And MRD Expansion? Earlier this week, Labcorp Holdings Inc. declared a quarterly cash dividend of US$0.72 per share, payable on March 12, 2026 to shareholders of record as of February 27, 2026. In parallel, Labcorp expanded its Plasma Detect molecular residual disease portfolio with highly sensitive ctDNA tests for breast,
15-Jan-2026 3:14 PM CST - Yahoo Finance UK Labcorp to Announce Fourth Quarter Financial Results on February 17, 2026 Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the fourth quarter of 2025 before the market opens on Tuesday,
13-Jan-2026 6:45 AM CST - Yahoo Finance Labcorp Expands MRD Testing for Breast, Lung and Colon Cancer Recurrence Risk Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the continued expansion of its molecular residual disease (MRD)i portfolio designed to help clinicians detect cancer recurrence earlier than traditional imaging.
31-Dec-2025 9:01 AM CST - Investing Snacks Labcorp Investor Conference at J.P. Morgan Labcorp will host a fireside chat at the J.P. Morgan Healthcare Conference. Get details on the Labcorp investor conference, webcast, and replay for their business outlook.
9-Dec-2025 3:50 AM CST - Yahoo Finance Labcorp (LH) Valuation Check After Steady Share Price Climb and Solid Total Return Labcorp Holdings (LH) has quietly outperformed many healthcare peers this year, and the stock's recent move has investors asking whether steady earnings growth and diagnostics demand can keep driving gains from here.
25-Nov-2025 6:04 PM CST - Yahoo Finance Labcorp Holdings Stock: Analyst Estimates & Ratings While Labcorp Holdings has underperformed the S&P 500 Index slightly over the past year, its YTD strength stands out. Analysts remain firmly bullish on the stock's growth potential.
